# Ultra-fast MRI for brain-age prediction in a real-world cognitive disorders clinic

**Authors:** Rafael Navarro-González, Rodrigo de Luis-García, Santiago Aja-Fernández, Wei Liu, Daniel C. Alexander, Frederik Barkhof, Millie Beament, Haroon R. Chughtai, Nick C. Fox, Catherine J. Mummery, Miguel Rosa-Grilo, David L. Thomas, Geoff J. M. Parker, James H. Cole

PMC · DOI: 10.3389/fnagi.2026.1731909 · Frontiers in Aging Neuroscience · 2026-03-18

## TL;DR

Ultra-fast MRI scans can predict brain age as accurately as standard scans, but may need adjustments when combined with traditional data.

## Contribution

Demonstrates the viability of ultra-fast MRI for brain-age prediction in clinical settings with minimal loss of accuracy.

## Key findings

- Ultra-fast Wave-CAIPI MRI showed excellent cross-protocol agreement with standard scans (ICC ≳ 0.90).
- Clinical discrimination between memory complaints and neurodegenerative disorders was comparable across protocols.
- Model-specific offsets and acquisition-by-diagnosis interactions suggest the need for harmonization when combining data.

## Abstract

Alzheimer’s trials and memory-clinic workflows require frequent structural MRI, but standard 3D-T1 MPRAGE can be burdensome and motion-prone. The Wave-CAIPI sequence offers major time savings, yet it is unclear whether these ultra-fast scans can be used to derive dementia-related biomarkers from models that have been trained on standard scans.

We acquired paired scans from the standard and Wave-CAIPI MPRAGE protocols in 147 patients from a cognitive disorders clinic and generated measures of the brain’s biological age. We applied six public brain-age pipelines (brainageR, DeepBrainNet, PyBrainAge, ENIGMA, pyment, MCCQR-MLP) to assess variability across software packages. We evaluated accuracy, interchangeability, cross-protocol agreement and clinical discrimination (subjective memory complaints versus neurodegenerative disorders), and tested effects of acquisition, diagnosis, and its interaction in a mixed-effects model.

Cross-protocol agreement was excellent across brain-age pipelines (intraclass correlation coefficient: ICC ≳ 0.90). Clinical discrimination was comparable between protocols, with effect sizes varying modestly by model-protocol combinations. Small, model-specific offsets and significant acquisition-by-diagnosis interactions were seen for some pipelines, consistent with a calibratable protocol effect; test–retest reliability was high and quality control measures were similar across protocols.

The ultra-fast Wave-CAIPI protocol could generate robust brain-age estimates in memory clinic patients, while markedly reducing scan time. When mixing ultra-fast and standard scans, a harmonization or transfer learning step is advisable to remove model-dependent offsets.

## Full-text entities

- **Diseases:** Alzheimer (MESH:D000544), memory complaints (MESH:D008569), dementia (MESH:D003704), cognitive disorders (MESH:D003072), neurodegenerative disorders (MESH:D019636)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13038902/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13038902/full.md

## References

56 references — full list in the complete paper: https://tomesphere.com/paper/PMC13038902/full.md

---
Source: https://tomesphere.com/paper/PMC13038902